本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vitro Biopharma

成交量:- -
成交額:- -
市值:- -
市盈率:- -
高:- -
開:- -
低:- -
收:- -
52周最高:- -
52周最低:- -
股本:451.77萬
流通股本:181.82萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9380
淨資產收益率:-614.04%
總資產收益率:-59.74%
市淨率:0.00
市盈率(LYR):- -

資料載入中...

2026/03/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/09/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/20

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/20

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/01/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/09/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/30

SEC問詢函

Form CORRESP - Correspondence
2024/08/24

SEC問詢函

Form CORRESP - Correspondence
2024/08/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/09

SEC問詢函

Form CORRESP - Correspondence
2024/08/08

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/02

SEC問詢函

Form CORRESP - Correspondence
2024/07/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/05/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]